Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 14 studies | 35% ± 15% | |
fibroblast | 10 studies | 26% ± 11% | |
macrophage | 9 studies | 23% ± 8% | |
smooth muscle cell | 6 studies | 24% ± 4% | |
B cell | 5 studies | 30% ± 11% | |
myeloid cell | 5 studies | 26% ± 10% | |
ciliated cell | 5 studies | 25% ± 4% | |
pericyte | 5 studies | 25% ± 4% | |
mast cell | 4 studies | 20% ± 2% | |
retinal ganglion cell | 4 studies | 38% ± 18% | |
epithelial cell | 4 studies | 29% ± 8% | |
adipocyte | 4 studies | 33% ± 21% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 4% | |
alveolar macrophage | 3 studies | 22% ± 3% | |
naive B cell | 3 studies | 17% ± 2% | |
basal cell | 3 studies | 25% ± 11% | |
neuron | 3 studies | 26% ± 6% | |
astrocyte | 3 studies | 31% ± 2% | |
glutamatergic neuron | 3 studies | 25% ± 11% | |
abnormal cell | 3 studies | 19% ± 1% | |
leukocyte | 3 studies | 20% ± 3% | |
endothelial cell | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 4870.07 | 89 / 89 | 100% | 224.41 | 901 / 901 |
ovary | 100% | 5102.43 | 180 / 180 | 100% | 173.81 | 430 / 430 |
thymus | 100% | 5909.36 | 653 / 653 | 100% | 136.66 | 605 / 605 |
skin | 100% | 4442.43 | 1806 / 1809 | 100% | 260.83 | 472 / 472 |
uterus | 100% | 5901.91 | 170 / 170 | 100% | 131.52 | 458 / 459 |
prostate | 100% | 6140.35 | 245 / 245 | 99% | 136.50 | 499 / 502 |
brain | 99% | 4700.14 | 2623 / 2642 | 100% | 177.54 | 705 / 705 |
adrenal gland | 100% | 4912.66 | 258 / 258 | 99% | 179.32 | 228 / 230 |
lung | 100% | 5396.90 | 576 / 578 | 99% | 123.93 | 1145 / 1155 |
breast | 100% | 9231.94 | 459 / 459 | 99% | 132.26 | 1103 / 1118 |
pancreas | 100% | 3161.87 | 327 / 328 | 99% | 161.59 | 176 / 178 |
esophagus | 99% | 5728.77 | 1432 / 1445 | 99% | 86.39 | 181 / 183 |
bladder | 100% | 7305.48 | 21 / 21 | 97% | 106.93 | 490 / 504 |
intestine | 99% | 6275.32 | 958 / 966 | 97% | 85.48 | 512 / 527 |
stomach | 100% | 4468.17 | 359 / 359 | 96% | 93.21 | 275 / 286 |
liver | 60% | 1093.80 | 136 / 226 | 69% | 70.99 | 281 / 406 |
adipose | 100% | 12512.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9437.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 419.30 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 176.53 | 29 / 29 |
spleen | 100% | 3839.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 109.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 194.13 | 1 / 1 |
heart | 100% | 9236.48 | 860 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 4363.04 | 797 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 45% | 1328.32 | 414 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0060754 | Biological process | positive regulation of mast cell chemotaxis |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0050918 | Biological process | positive chemotaxis |
GO_0060976 | Biological process | coronary vasculature development |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0038084 | Biological process | vascular endothelial growth factor signaling pathway |
GO_0002040 | Biological process | sprouting angiogenesis |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0001666 | Biological process | response to hypoxia |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
GO_0050930 | Biological process | induction of positive chemotaxis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0008201 | Molecular function | heparin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0042056 | Molecular function | chemoattractant activity |
GO_0005172 | Molecular function | vascular endothelial growth factor receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | VEGFB |
Protein name | Vascular endothelial growth factor B Vascular endothelial growth factor B (VEGF-B) (VEGF-related factor) (VRF) Vascular endothelial growth factor B isoform VEGF-B167 |
Synonyms | VRF |
Description | FUNCTION: Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis. |
Accessions | ENST00000541681.1 ENST00000309422.7 [P49765-1] H0YGB6 Q7LAP4 ENST00000426086.3 [P49765-2] P49765 Q8TEV2 |